Propylamine

Propylamine

SCHEMBL942324

CCCCCCCCCCCCC#CC#CCCCC(N)=O.CCCN

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN7 P35236 5/20 0.66
▸ HMGCR P04035 7/20 0.61
▸ RECQL P46063 2/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ SELP P16109 1/20 0.50
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ BLM P54132 1/20 0.47
▸ MCL1 Q07820 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ FAAH O00519 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3796753 0.94 PTPN7 (0.72) PTPN7HMGCRRECQLTDP1SELP
SCHEMBL4453291 0.94 PTPN7 (0.72) PTPN7HMGCRRECQLTDP1SELP
Alcohol SCHEMBL6424529 0.91 PTPN7 (0.68) PTPN7HMGCRRECQLTDP1SELP
SCHEMBL2201502 0.91 HMGCR (0.72) PTPN7HMGCRRECQLTDP1SELP
SCHEMBL2182049 0.91 HMGCR (0.72) PTPN7HMGCRRECQLTDP1SELP
SCHEMBL2180780 0.91 HMGCR (0.72) PTPN7HMGCRRECQLTDP1SELP
SCHEMBL1918073 0.91 HMGCR (0.72) PTPN7HMGCRRECQLTDP1SELP
SCHEMBL4231623 0.91 HMGCR (0.72) PTPN7HMGCRRECQLTDP1SELP
SCHEMBL2181335 0.91 HMGCR (0.72) PTPN7HMGCRRECQLTDP1SELP
SCHEMBL4225757 0.91 HMGCR (0.72) PTPN7HMGCRRECQLTDP1SELP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030103905-A1 Methods and compositions for preparing consumables with optical shifting properties SEGAN INDUSTRIES 2003-06-05 — — US claimed
EP-1297333-A2 INGESTIBLES POSSESSING INTRINSIC COLOR CHANGE Segan Industries, Inc. (US) 2003-04-02 — — EP claimed
US-20020034475-A1 Ingestibles possessing intrinsic color change SEGAN INDUSTRIES 2002-03-21 — — US claimed
WO-2002000920-A2 INGESTIBLES POSSESSING INTRINSIC COLOR CHANGE SEGAN INDUSTRIES, INC. (US) 2002-01-03 — — WO claimed
US-20130040020-A1 Methods and Compositions for Preparing Consumables with Optical Shifting Properties SEGAN INDUSTRIES, INC. 2013-02-14 — — US disclosed
US-20110008498-A1 Methods and Compositions for Preparing Consumables with Optical Shifting Properties SEGAN INDUSTRIES, INC. 2011-01-13 — — US disclosed
US-7776371-B2 Methods and compositions for preparing consumables with optical shifting properties SEGAN INDUSTRIES INC. (US) 2010-08-17 — — US disclosed
EP-2128610-A2 Ingestibles possessing intrinsic color change Segan Industries, Inc. (US) 2009-12-02 — — EP disclosed
US-20070071680-A1 Methods and compositions for preparing consumables with optical shifting properties SEGAN INDUSTRIES, INC. 2007-03-29 — — US disclosed
US-20030103905-A1 Methods and compositions for preparing consumables with optical shifting properties SEGAN INDUSTRIES 2003-06-05 — — US disclosed
EP-1297333-A2 INGESTIBLES POSSESSING INTRINSIC COLOR CHANGE Segan Industries, Inc. (US) 2003-04-02 — — EP disclosed
US-20020034475-A1 Ingestibles possessing intrinsic color change SEGAN INDUSTRIES 2002-03-21 — — US disclosed
WO-2002000920-A2 INGESTIBLES POSSESSING INTRINSIC COLOR CHANGE SEGAN INDUSTRIES, INC. (US) 2002-01-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030103905-A1 Methods and compositions for preparing consumables with optical shifting properties TAS2R46, THEM6, TAS2R41 PTPN7 3762/4885HMGCR 4673/4885RECQL 1712/4885
US-20020034475-A1 Ingestibles possessing intrinsic color change TAS2R46, THEM6, TAS2R16 PTPN7 3807/4885HMGCR 4428/4885RECQL 1531/4885
US-20070071680-A1 Methods and compositions for preparing consumables with optical shifting properties TAS2R46, THEM6, TAS2R41 PTPN7 3762/4885HMGCR 4673/4885RECQL 1712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback